Metraipolis › archive › dc_5e2a285233ec
Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study — Europe PMC PMID:40922413
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40922413
- DOI
- 10.1111/1346-8138.17950
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T01:51:33.856Z
- SHA-256 of the archived text
2c6a169c087a4a2409362998d3c2c204988790bc08a144cd4711dc9504b8e73a- Stable URL of this page
https://metraipolis.com/documento/dc_5e2a285233ec
How to cite
Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study — Europe PMC PMID:40922413 — Europe PMC (en), https://europepmc.org/article/MED/40922413 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5e2a285233ec (Metraipolis archive dc_5e2a285233ec, sha256 2c6a169c087a4a2409362998d3c2c204988790bc08a144cd4711dc9504b8e73a)
BibTeX
@misc{dc5e2a285233ec,
title = {Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study — Europe PMC PMID:40922413},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40922413},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5e2a285233ec; sha256 2c6a169c087a4a2409362998d3c2c204988790bc08a144cd4711dc9504b8e73a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40922413. Agents can read the archived copy with the MCP tool read_document.